• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞质热休克蛋白 70 作为预测胶质母细胞瘤患者临床结局的生物标志物。

Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.

机构信息

Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Institute of Pathology, Technical University of Munich, Munich, Germany.

出版信息

PLoS One. 2019 Aug 20;14(8):e0221502. doi: 10.1371/journal.pone.0221502. eCollection 2019.

DOI:10.1371/journal.pone.0221502
PMID:31430337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6701831/
Abstract

INTRODUCTION

The major stress-inducible heat shock protein 70 (Hsp70) is induced after different stress stimuli. In tumors, elevated intracellular Hsp70 levels were associated on the one hand with radio- and chemotherapy resistance and on the other hand with a favorable outcome for patients. This study was undertaken to investigate cytosolic Hsp70 (cHsp70) as a potential biomarker for progression free (PFS) and overall survival (OS) in patients with primary glioblastomas (GBM).

METHODS

The cHsp70 expression in tumor tissue of 60 patients diagnosed with primary GBM was analyzed by immunohistochemistry. The cHsp70 expression was correlated to the PFS and OS of the patients.

RESULTS

A high cHsp70 expression was associated with a prolonged PFS (hazard ratio = 0.374, p = 0.001) and OS (hazard ratio = 0.416, p = 0.014) in GBM patients treated according to the standard Stupp protocol with surgery, radiotherapy and temozolomide.

CONCLUSIONS

These data suggest that the intracellular Hsp70 expression might serve as a prognostic marker in patients with primary GBM.

摘要

简介

主要的应激诱导热休克蛋白 70(Hsp70)在受到不同应激刺激后会被诱导产生。在肿瘤中,细胞内 Hsp70 水平的升高一方面与放射和化学疗法耐药有关,另一方面与患者的良好预后有关。本研究旨在探讨细胞质 Hsp70(cHsp70)作为原发性神经胶质瘤(GBM)患者无进展生存期(PFS)和总生存期(OS)的潜在生物标志物。

方法

通过免疫组织化学分析 60 例原发性 GBM 患者肿瘤组织中的 cHsp70 表达。将 cHsp70 表达与患者的 PFS 和 OS 相关联。

结果

根据 Stupp 标准方案(手术、放疗和替莫唑胺)治疗的 GBM 患者中,高 cHsp70 表达与延长的 PFS(风险比=0.374,p=0.001)和 OS(风险比=0.416,p=0.014)相关。

结论

这些数据表明,细胞内 Hsp70 表达可能作为原发性 GBM 患者的预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/839d/6701831/3b031a9ad825/pone.0221502.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/839d/6701831/96cad3f49ab2/pone.0221502.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/839d/6701831/34cbe1864591/pone.0221502.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/839d/6701831/969d01cd2bf3/pone.0221502.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/839d/6701831/6b57231c7c82/pone.0221502.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/839d/6701831/3b031a9ad825/pone.0221502.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/839d/6701831/96cad3f49ab2/pone.0221502.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/839d/6701831/34cbe1864591/pone.0221502.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/839d/6701831/969d01cd2bf3/pone.0221502.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/839d/6701831/6b57231c7c82/pone.0221502.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/839d/6701831/3b031a9ad825/pone.0221502.g005.jpg

相似文献

1
Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.细胞质热休克蛋白 70 作为预测胶质母细胞瘤患者临床结局的生物标志物。
PLoS One. 2019 Aug 20;14(8):e0221502. doi: 10.1371/journal.pone.0221502. eCollection 2019.
2
Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas.在原发性神经胶质瘤中细胞溶质、质膜结合和细胞外热休克蛋白 70(Hsp70)的过表达。
J Neurooncol. 2017 Dec;135(3):443-452. doi: 10.1007/s11060-017-2600-z. Epub 2017 Aug 28.
3
Stanniocalcin-2 expression in glioblastoma - A novel prognostic biomarker: An observational study.Stanniocalcin-2 在胶质母细胞瘤中的表达-一种新的预后生物标志物:一项观察性研究。
Medicine (Baltimore). 2024 Jul 12;103(28):e38913. doi: 10.1097/MD.0000000000038913.
4
Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.原发性多形性胶质母细胞瘤肿瘤与复发:危险信号高迁移率族蛋白B1、热休克蛋白70和钙网蛋白的比较分析
Strahlenther Onkol. 2016 Mar;192(3):146-55. doi: 10.1007/s00066-015-0926-z. Epub 2015 Dec 8.
5
Immunohistochemical analysis of O6-methylguanine-DNA methyltransferase (MGMT) protein expression as prognostic marker in glioblastoma patients treated with radiation therapy with concomitant and adjuvant Temozolomide.O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)蛋白表达的免疫组化分析作为接受放疗联合辅助替莫唑胺治疗的胶质母细胞瘤患者的预后标志物。
J Egypt Natl Canc Inst. 2016 Mar;28(1):23-30. doi: 10.1016/j.jnci.2015.11.003. Epub 2015 Dec 10.
6
Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM Tumors.转化生长因子-β异构体在 GBM 肿瘤中的差异表达及其临床意义。
Int J Mol Sci. 2018 Apr 8;19(4):1113. doi: 10.3390/ijms19041113.
7
Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme.碳酸酐酶IX是多形性胶质母细胞瘤中的一种预后生物标志物。
Neuropathology. 2018 Oct;38(5):457-462. doi: 10.1111/neup.12485. Epub 2018 Jun 28.
8
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide.表皮生长因子受体扩增和过表达的胶质母细胞瘤与对辅助性节拍式替莫唑胺治疗反应较好的相关性。
J Natl Cancer Inst. 2015 Mar 3;107(5). doi: 10.1093/jnci/djv041. Print 2015 May.
9
Investigation of serum levels and tissue expression of two genes IGFBP-2 and IGFBP-3 act as potential biomarker for predicting the progression and survival in patients with glioblastoma multiforme.研究IGFBP - 2和IGFBP - 3这两个基因的血清水平及组织表达,作为预测多形性胶质母细胞瘤患者病情进展和生存情况的潜在生物标志物。
J Neurol Sci. 2016 Jul 15;366:202-206. doi: 10.1016/j.jns.2016.05.018. Epub 2016 May 14.
10
Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.Survivin 亚细胞定位在接受放化疗联合替莫唑胺辅助治疗的胶质母细胞瘤中的预后意义。
J Neurosurg. 2018 Mar;128(3):679-684. doi: 10.3171/2016.11.JNS162326. Epub 2017 Apr 21.

引用本文的文献

1
The Confluence of Nanotechnology and Heat Shock Protein 70 in Pioneering Glioblastoma Multiforme Therapy: Forging Pathways Towards Precision Targeting and Transformation.纳米技术与热休克蛋白70在多形性胶质母细胞瘤开创性治疗中的融合:开创精准靶向与转化之路。
Adv Pharmacol Pharm Sci. 2025 Apr 24;2025:1847197. doi: 10.1155/adpp/1847197. eCollection 2025.
2
Clinical Feature Ranking Based on Ensemble Machine Learning Reveals Top Survival Factors for Glioblastoma Multiforme.基于集成机器学习的临床特征排序揭示多形性胶质母细胞瘤的首要生存因素
J Healthc Inform Res. 2023 Sep 20;8(1):1-18. doi: 10.1007/s41666-023-00138-1. eCollection 2024 Mar.
3

本文引用的文献

1
Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas.在原发性神经胶质瘤中细胞溶质、质膜结合和细胞外热休克蛋白 70(Hsp70)的过表达。
J Neurooncol. 2017 Dec;135(3):443-452. doi: 10.1007/s11060-017-2600-z. Epub 2017 Aug 28.
2
The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials.胶质母细胞瘤中 MGMT 启动子甲基化的预后价值:临床试验的荟萃分析。
J Cell Physiol. 2018 Jan;233(1):378-386. doi: 10.1002/jcp.25896. Epub 2017 May 16.
3
Immune phenotypes predict survival in patients with glioblastoma multiforme.
Targeting Heat Shock Proteins in Malignant Brain Tumors: From Basic Research to Clinical Trials.
靶向恶性脑肿瘤中的热休克蛋白:从基础研究到临床试验
Cancers (Basel). 2022 Nov 4;14(21):5435. doi: 10.3390/cancers14215435.
4
Betulin and Its Derivatives Reduce Inflammation and COX-2 Activity in Macrophages.白桦脂醇及其衍生物可降低巨噬细胞炎症反应和环氧化酶-2 活性。
Inflammation. 2023 Apr;46(2):573-583. doi: 10.1007/s10753-022-01756-4. Epub 2022 Oct 25.
5
An Overview on Immunogenic Cell Death in Cancer Biology and Therapy.癌症生物学与治疗中的免疫原性细胞死亡概述
Pharmaceutics. 2022 Jul 27;14(8):1564. doi: 10.3390/pharmaceutics14081564.
6
Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker.免疫原性细胞死亡、损伤相关分子模式与胸腺素α原作为一种潜在的抗癌免疫反应生物标志物
Cells. 2022 Apr 22;11(9):1415. doi: 10.3390/cells11091415.
7
Immunogenic Cell Death Induction by Ionizing Radiation.电离辐射诱导的免疫原性细胞死亡。
Front Immunol. 2021 Aug 20;12:705361. doi: 10.3389/fimmu.2021.705361. eCollection 2021.
8
Biomarkers of Radiotherapy-Induced Immunogenic Cell Death.放疗诱导免疫原性细胞死亡的生物标志物。
Cells. 2021 Apr 17;10(4):930. doi: 10.3390/cells10040930.
9
Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients.用于构建肝细胞癌患者免疫遗传模型的机器学习
J Oncol. 2021 Mar 17;2021:6676537. doi: 10.1155/2021/6676537. eCollection 2021.
10
Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.更正:胞质热休克蛋白70作为预测胶质母细胞瘤患者临床结局的生物标志物。
PLoS One. 2021 Mar 11;16(3):e0248612. doi: 10.1371/journal.pone.0248612. eCollection 2021.
免疫表型可预测多形性胶质母细胞瘤患者的生存率。
J Hematol Oncol. 2016 Sep 1;9(1):77. doi: 10.1186/s13045-016-0272-3.
4
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.2016 年世界卫生组织中枢神经系统肿瘤分类:概述。
Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.
5
BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma.BAG-1/SODD、热休克蛋白70(HSP70)和热休克蛋白90(HSP90)是淋巴结阴性乳腺癌患者生存预后不良的潜在标志物。
Hum Pathol. 2016 Aug;54:64-73. doi: 10.1016/j.humpath.2016.02.023. Epub 2016 Mar 30.
6
Stress Response Leading to Resistance in Glioblastoma-The Need for Innovative Radiotherapy (iRT) Concepts.应激反应导致胶质母细胞瘤耐药——创新性放疗(iRT)概念的必要性。
Cancers (Basel). 2016 Jan 13;8(1):15. doi: 10.3390/cancers8010015.
7
Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain.自然杀伤(NK)细胞可抑制胶质母细胞瘤细胞的全身转移,并对脑部的胶质母细胞瘤具有治疗作用。
BMC Cancer. 2015 Dec 24;15:1011. doi: 10.1186/s12885-015-2034-y.
8
Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.原发性多形性胶质母细胞瘤肿瘤与复发:危险信号高迁移率族蛋白B1、热休克蛋白70和钙网蛋白的比较分析
Strahlenther Onkol. 2016 Mar;192(3):146-55. doi: 10.1007/s00066-015-0926-z. Epub 2015 Dec 8.
9
Correlation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer.鳞状细胞癌和腺性非小细胞肺癌患者血清Hsp70水平与肿瘤总体积及淋巴细胞亚群组成的相关性
Front Immunol. 2015 Nov 2;6:556. doi: 10.3389/fimmu.2015.00556. eCollection 2015.
10
Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II Trial.热休克蛋白70(Hsp70)肽激活自然杀伤(NK)细胞用于放化疗(RCTx)后非小细胞肺癌(NSCLC)患者的治疗——从临床前研究到临床II期试验
Front Immunol. 2015 Apr 15;6:162. doi: 10.3389/fimmu.2015.00162. eCollection 2015.